BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11064570)

  • 41. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer.
    Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M
    J BUON; 2008; 13(1):51-4. PubMed ID: 18404786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early cervical cancer and parametrial involvement: is it significant?
    Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
    Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Digital image analysis in pathology--exemplified in prostatic cancer].
    Danielsen HE; Kildal W; Sudbø J
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):479-88. PubMed ID: 10833941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and biological significance of cellular DNA content and nuclear size in carcinoma of the uterine cervix].
    Gu Q
    Zhonghua Yi Xue Za Zhi; 1990 Dec; 70(12):703-5. PubMed ID: 1963378
    [No Abstract]   [Full Text] [Related]  

  • 47. Cellular DNA contact and its correlation with histopathological prognostic parameters in carcinoma of the breast.
    Chaturvedi S; Singh S; Khanna HD; Khanna S; Khanna R
    Indian J Pathol Microbiol; 1998 Jul; 41(3):337-42. PubMed ID: 9805857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry.
    Nguyen HN; Sevin BU; Averette HE; Ramos R; Ganjei P; Perras J
    Cancer; 1993 Apr; 71(8):2543-50. PubMed ID: 8453577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of DNA distribution and cytological differentiation of human cervical carcinomas.
    Jakobsen A; Bichel P; Sell A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1979; 31(1):75-9. PubMed ID: 42204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical assessment of the growth fraction in cervical cancers using the monoclonal antibody Ki-67; relationship to the clinical stage, histologic type and DNA content.
    Masuda T; Yabushita H; Sawaguchi K; Noguchi M; Nakanishi M
    Asia Oceania J Obstet Gynaecol; 1992 Mar; 18(1):81-7. PubMed ID: 1627063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA ploidy and S-phase fraction as prognostic factors in cervical cancer.
    Rothenberg ML
    Cancer Treat Res; 1994; 70():53-62. PubMed ID: 8060751
    [No Abstract]   [Full Text] [Related]  

  • 52. Mitotic modifications and aberrations in cancer.
    Therman E; Kuhn EM
    Crit Rev Oncog; 1989; 1(3):293-305. PubMed ID: 2488134
    [No Abstract]   [Full Text] [Related]  

  • 53. Evolutionary somatic cell changes in cervical tumour progression quantitatively evaluated with morphological, histochemical and kinetic parameters.
    Mariuzzi G; Sisti S; Santinelli A; Valli M; Mariuzzi L
    Pathol Res Pract; 1992 Jun; 188(4-5):454-60. PubMed ID: 1409071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computer grading of cervical intraepithelial neoplastic lesions. I. Cytologic indices.
    Wied GL; Bibbo M; Dytch HE; Bartels PH
    Anal Quant Cytol Histol; 1985 Mar; 7(1):52-60. PubMed ID: 4003966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Molecular genetics of uterine cervical cancer: application to prognosis].
    Riou G
    Rev Prat; 1990 Jan; 40(3):239-41. PubMed ID: 2406878
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prognostic factors in cervical cancer].
    Hashimoto K; Hirabayashi K
    Saishin Igaku; 1971 Jan; 27(1):128-34. PubMed ID: 5141559
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cancer register for cervix carcinoma--useful and necessary?].
    Horn LC; Bilek K
    Zentralbl Gynakol; 2001 May; 123(5):311-4. PubMed ID: 11449625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microinvasive cervical cancer: the problem of studying a disease with an excellent prognosis.
    Copeland LJ
    Gynecol Oncol; 1996 Oct; 63(1):1-3. PubMed ID: 8898158
    [No Abstract]   [Full Text] [Related]  

  • 59. Prognostic factors and endometrial carcinoma.
    Pfleiderer A; Kleine W; Maier T; Schwörer D; Geyer H; Kaufmehl K
    Eur J Gynaecol Oncol; 1989; 10(3):186-91. PubMed ID: 2543578
    [No Abstract]   [Full Text] [Related]  

  • 60. Discriminant analysis for classification of murine melanomas and human cervical epithelial cells.
    Hallouche F; Adams AE; Hinton OR; Surtees DP; Wadehra V; Sherbet GV
    Anal Quant Cytol Histol; 1993 Feb; 15(1):50-60. PubMed ID: 8471106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.